共 31 条
- [31] A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 871 - 882